Dr. David Zahavi is an AAAS Fellow in the Epidemiology and Genomics Research Program's (EGRP) Risk Factor Assessment Branch (RFAB). In this role, he works on digital health projects, including the National Institutes of Health and National Science Foundation Smart Health Program and the CancerX Initiative.
Before joining EGRP, Dr. Zahavi was a postdoctoral fellow in the Center of Immuno-Oncology in NCI's Center for Cancer Research (CCR), where he worked on translational projects involving new therapeutics. During his fellowship, he designed and implemented independent research projects involving work with mouse models of cancer to evaluate novel immunotherapeutic combinations.
Dr. Zahavi received his doctoral degree in tumor biology and master's degree in physiology from Georgetown University. During his time at Georgetown University, he was a member of the Program Oversight Committee for Georgetown's Tumor Biology Program, a grant reviewer for a student research grant program, and a teaching assistant for a lecture series on clinical and translational oncology. His research interests include personalized medicine approaches and the development and implementation of cutting-edge technologies in cancer care.